AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5
slide-6

Lupin Mira 50 Tablet ER

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Mirabegron (50mg)

Overview Lupin Mira 50 Tablet ER

Mira 50 Extended-Release tablets, manufactured by Lupin, alleviate overactive bladder symptoms such as urinary frequency, urgency, and incontinence. This medication relaxes bladder muscles, improving urinary capacity. Always adhere to your physician's prescribed dosage and duration. It may be taken with or without food; swallow the tablet whole—do not crush or chew. Discontinue use only after consulting your doctor, as premature cessation may exacerbate symptoms. Complete the prescribed course for optimal therapeutic benefit. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infections, tachycardia, and arthralgia. Report any bothersome or persistent side effects promptly to your doctor. Prior to treatment, disclose all current medications and any pre-existing medical conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their doctor.

Primary Ingredients of Lupin Mira 50 Tablet ER

No text provided to rephrase.

Uses of Lupin Mira 50 Tablet ER

Managing symptoms associated with overactive bladder

Major Benefits of Lupin Mira 50 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Lupin Mira 50 ER tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. While you can take them with or without food, consistent timing is recommended.

Common Side effects of Lupin Mira 50 Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Lupin Mira 50 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Lupin Mira 50 Tablet ER whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistent timing is recommended.

How Lupin Mira 50 Tablet ER works:

Mira 50 Extended-Release tablets (Lupin) contain a beta-3 adrenergic agonist. This medication acts by stimulating bladder beta-3 receptors, resulting in bladder muscle relaxation and a reduction in urinary urgency, frequency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Use caution when combining Lupin Mira 50 Tablet ER and alcohol. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Lupin Mira 50 Tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Lupin Mira 50 tablets are likely not safe for breastfeeding mothers. Studies in humans indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Lupin Mira 50 Tablet ER.

KidneyKidneyCAUTION

Patients with severe kidney impairment should use extended-release Mira 50 tablets (Lupin) cautiously; dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Mira 50 ER tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Mira 50 ER tablets are contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Lupin Mira 50 Tablet ER :

Should you forget a dose of Lupin Mira 50 Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Lupin Mira 50 Tablet ER

LabelValue
Chemical Type Anilide-based compound
Developing Habits No.
Treatment Category Urology
Actions Beta-3 agonist for bladder control

FAQs on Lupin Mira 50 Tablet ER

Experience the full effects of Lupin Mira 50 Tablet ER typically within 8 weeks, or potentially longer. Dosage adjustments may be considered after 4 to 8 weeks, based on individual response.
Continue taking Lupin Mira 50 Tablet ER even if your symptoms improve. This medication doesn't cure overactive bladder; it manages urgency, frequency, and incontinence. Stopping treatment could cause your symptoms to return.
Lupin Mira 50 Tablet ER shouldn't interfere with your sleep. Consult your doctor about any sleep issues you experience.
Lupin Mira 50 Tablet ER should not be given to children under 18 because its safety and efficacy haven't been established in this age group.
No, consistent daily use, as prescribed, is crucial. This medication manages your condition, not curing it. Intermittent use prevents your bladder from adapting fully, leading to ineffective treatment and symptom recurrence.
Lupin Mira 50 Tablet ER may cause infections of the kidneys, ureters, bladder, or urethra, though this is not universal. Renal stones and bladder pain have been reported in a small number of patients. Individuals with impaired kidney function should use caution and promptly report any kidney-related side effects to their physician.
Caution is advised when taking Lupin Mira 50 Tablet ER if you have high blood pressure. Regular blood pressure monitoring is recommended, as this medication may raise blood pressure in some individuals. It's contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help, regardless of symptoms. A Lupin Mira 50 Tablet ER overdose can elevate heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Lupin Mira 50 Tablet ER
447
MRP 545
17% off